Hong-An Truong

Title: Innovations and Contributions of Inventor Hong-An Truong

Introduction

Hong-An Truong is a notable inventor based in San Francisco, CA, with a significant portfolio of six patents. His work primarily focuses on the development of antibodies for therapeutic applications, particularly in the field of immunology and cancer treatment.

Latest Patents

Among his latest patents, one includes antibodies binding to ILT4, which specifically target immunoglobulin-like transcript 4 (ILT4). This invention is crucial as it provides a means to develop therapies that selectively interact with human ILT4 while avoiding significant binding to other related proteins. Another significant patent involves antibodies against TIM3, which are designed for therapeutic applications in cancer treatment. This patent outlines the production of these antibodies, their uses, and the corresponding polynucleotides that encode their heavy and light chain regions.

Career Highlights

Throughout his career, Hong-An Truong has worked with prominent companies in the biotechnology sector, including Bristol-Myers Squibb Company and Five Prime Therapeutics, Inc. His contributions in these organizations have been instrumental in advancing research and development in antibody therapies.

Collaborations

Hong-An has collaborated with several professionals in his field, including Xiao Min Schebye and Mark J Selby. These collaborations have further enriched his research and innovation efforts.

Conclusion

In summary, Hong-An Truong's contributions to the field of immunology through his innovative patents and collaborations highlight his significant role as an inventor. His work continues to pave the way for advancements in therapeutic applications.